PAREXEL RECIST 1.1

iOS Universel / Medecine

Learn about RECIST 1.1 and how it can be applied to your clinical trial.

RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.

Quoi de neuf dans la dernière version ?

This app has been updated by Apple to display the Apple Watch app icon.

Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.